Jump to content

Category:Mark K. Schlegel of Boston MA (US)

From WikiTrademarks

Mark K. Schlegel of Boston MA (US)

Executive Summary

Mark K. Schlegel of Boston MA (US) is an inventor who has filed 4 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (4 patents), of the backbone (3 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (3 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (4 patents). Their most frequent collaborators include (3 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Mark K. Schlegel of Boston MA (US) Monthly Patent Applications.png

Technology Areas

File:Mark K. Schlegel of Boston MA (US) Top Technology Areas.png

List of Technology Areas

  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 4 patents
  • C12N2310/315 (of the backbone): 3 patents
  • C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
  • C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
  • C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • A61P25/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C12N2310/312 (of the backbone): 1 patents
  • C12N2310/321 (2'-O-R Modification): 1 patents
  • C12N2310/322 (2'-R Modification): 1 patents
  • A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
  • A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:Mark K. Schlegel of Boston MA (US) Top Companies.png

List of Companies

  • Alnylam Pharmaceuticals, Inc.: 4 patents

Collaborators

Subcategories

This category has the following 10 subcategories, out of 10 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.